Several companies—including JCR Pharmaceuticals, Denali Therapeutics and Regenxbio— have products in the pipeline that could ...

Authorities took Hunter Nicholas Hines ... he’s already accused of victimizing a 14-year-old boy with Asperger’s syndrome in 2022 when he was living in the Vero Beach area.

Hunter Nicholas Hines ... Investigators obtained surveillance images of the suspect and used facial recognition software to identify him as Hines. Hines, who lives in Pembroke Pines, was later ...

Hunter Nicholas Hines ... Investigators obtained surveillance images of the suspect and used facial recognition software to identify him as Hines. Hines, who lives in Pembroke Pines, was later ...

With an FDA approval submission for RegenXBio’s Hunter syndrome gene therapy already underway, the biopharma has now found a commercialization partner for both the U.S. and Asian markets.

Denali’s wholly owned program, DNL310 or tividenofusp alfa, is an Enzyme Transport Vehicle-enabled iduronate-2-sulfatase (IDS) replacement therapy in development for MPS II (Hunter syndrome).

Fifteen-year-old Dominic Henriquez from Prosper, Texas, is bringing hope to boys like him who live with Hunter syndrome, a rare genetic disorder that primarily affects males. Dominic’s journey ...